NASDAQ:GRVI

Grove Stock Forecast, Price & News

$4.35

+0.24 (+5.84 %)

(As of 07/23/2021 12:00 AM ET)

Add

Compare

Today's Range

$4.01

▼

$4.35

50-Day Range N/A

52-Week Range

$3.86

▼

$9.37

Volume194,778 shs

Average Volume2.23 million shs

Market Capitalization$61.81 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive GRVI News and Ratings via Email

Sign-up to receive the latest news and ratings for Grove and its competitors with MarketBeat's FREE daily newsletter.

About Grove

Grove, Inc., through its subsidiaries, engages in developing, producing, marketing, and selling raw materials, white label products, and end consumer products containing the industrial hemp plant extract, cannabidiol. The company serves consumer markets, including the botanical, beauty care, pet care, and functional food sectors. It also operates annual tradeshow related to the CBD industry in the United States. Grove, Inc. was incorporated in 2018 and is headquartered in Henderson, Nevada.

Grove (NASDAQ:GRVI) Trading Down 2%
July 17, 2021 | americanbankingnews.com

Grove Inc.
July 14, 2021 | wsj.com

Grove Inc. - Launches Qubes Plant-Based Vitamin Gummy Brand
July 6, 2021 | benzinga.com

Grove Inc. Launches Qubes Plant-Based Vitamin Gummy Brand
July 6, 2021 | finance.yahoo.com

Grove Inc. Planning Entry Into Nutraceuticals with Vitamedica Agreement
June 30, 2021 | finance.yahoo.com

Grove Inc
June 28, 2021 | reuters.com

Grove, Inc. (GRVI)
June 27, 2021 | ca.finance.yahoo.com

Grove Shares Open For Trade At $5; IPO Priced At $5/Share
June 25, 2021 | benzinga.com

Grove Prices IPO of 2.2 Million Shares at $5 a Share
June 25, 2021 | marketwatch.com

Grove Inc. Shares Open Trading at $5 a Share
June 25, 2021 | marketwatch.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GRVI
Previous Symbol
CUSIPN/A
CIKN/A
WebN/A
Phone701-353-5425
Employees90
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares14,210,000
Market Cap$61.81 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

2174th out of 2,214 stocks

Medicinals & Botanicals Industry

36th out of 37 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Grove.

0.0 Community Rank

Outperform Votes
Grove has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Grove has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Grove and other stocks. Vote “Outperform” if you believe GRVI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GRVI will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Grove does not currently pay a dividend.
Dividend Growth
Grove does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Grove insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Grove (NASDAQ:GRVI) Frequently Asked Questions

What stocks does MarketBeat like better than Grove?

Wall Street analysts have given Grove a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Grove wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Grove's key executives?

Grove's management team includes the following people:

Mr. Allan J. Marshall, CEO & Chairman (Age 54, Pay $300k)
Mr. Robert Hackett, Pres (Age 37, Pay $130.91k)
Mr. Andrew J. Norstrud, CFO & Director (Age 49, Pay $184.23k)

Who are some of Grove's key competitors?

Some companies that are related to Grove include Natural Alternatives International (NAII), MediWound (MDWD), Bon Natural Life (BON), Mannatech (MTEX), Charlie's (CHUCD), Charlie's (CHUC), FitLife Brands (FTLF), Nutra Pharma (NPHC), Happiness Biotech Group (HAPP), Glucose Health (GLUC), Cyanotech (CYAN), Tauriga Sciences (TAUG), Exactus (EXDI), GLG Life Tech (GLGLF) and Beleave (BE).
View all of GRVI's competitors.

When did Grove IPO?

(GRVI) raised $11 million in an IPO on Thursday, June 24th 2021. The company issued 2,200,000 shares at $4.50-$5.50 per share.

What is Grove's stock symbol?

Grove trades on the NASDAQ under the ticker symbol "GRVI."

When does the company's quiet period expire?

Grove's quiet period expires on Tuesday, August 3rd. Grove had issued 2,200,000 shares in its IPO on June 24th. The total size of the offering was $11,000,000 based on an initial share price of $5.00. During the company's quiet period, insiders and any underwriters involved in the IPO are restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Grove?

Shares of GRVI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Grove's stock price today?

One share of GRVI stock can currently be purchased for approximately $4.35.

How much money does Grove make?

Grove has a market capitalization of $61.81 million.

How many employees does Grove have?

Grove employs 90 workers across the globe.

How can I contact Grove?

The company can be reached via phone at 701-353-5425.

This page was last updated on 7/25/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Grove Stock Forecast, Price & News

About Grove

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes